T
IONS icon

TOBAM’s Ionis Pharmaceuticals IONS Stock Holding History

TOBAM’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-598
Closed -$34K – 438
2020
Q4 		$34K Hold
598
– – ﹤0.01% 391
2020
Q3 		$28K Buy
+598
New +$33.2K ﹤0.01% 396
2016
Q3 		– Sell
-198,811
Closed -$4.63M – 117
2016
Q2 		$4.63M Buy
+198,811
New +$6.41M 0.19% 76
2016
Q1 		– Sell
-171,344
Closed -$10.6M – 128
2015
Q4 		$10.6M Buy
171,344
+106,309
+163% +$5.74M 0.46% 63
2015
Q3 		$2.63M Sell
65,035
-45,737
-41% -$2.37M 0.1% 102
2015
Q2 		$6.38M Buy
110,772
+18,927
+21% +$1.2M 0.23% 75
2015
Q1 		$5.85M Buy
+91,845
New +$6.23M 0.18% 78

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TOBAM's IONS Position: Q1 2021 in Review

TOBAM sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 598 shares — an estimated $34K sold.

TOBAM first reported a position in IONS in Q1 2015 and held it in 7 quarters. The position peaked at $10.6M in Q4 2015. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • TOBAM reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • TOBAM sold 598 Ionis Pharmaceuticals shares in Q1 2021, an estimated $34K.
  • TOBAM first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 7 quarters.
  • TOBAM's Ionis Pharmaceuticals position peaked at $10.6M in Q4 2015.
  • 364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on TOBAM's 13F filing for Q1 2021, filed 11 May 2021.